Clinically and orally compatible formulation-manufactured DDX5 (p68)-targeting molecular glue FL118 products exhibit low toxicity but high efficacy against human cancer
Spremljeno u:
| Glavni autori: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2024-11-01
|
| Serija: | Journal of Pharmaceutical Analysis |
| Online pristup: | http://www.sciencedirect.com/science/article/pii/S2095177924000984 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|